Ironwood Pharmaceuticals INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Sarissa Capital Management LP and Alexander J. Denner have reduced their beneficial ownership in Ironwood Pharmaceuticals Inc. to 5.6% and 5.8% respectively, following significant share sales.